July 28, 2026
3 min watch
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Systemic statin use reduced the rate of proliferative vitreoretinopathy and reoperation following primary retinal detachment repair by nearly half, according to a speaker at the American Society of Retina Specialists annual meeting.
July 28, 2026
3 min watch
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Hazard for proliferative vitreoretinopathy, complex reoperation almost 50% lower

WASHINGTON — A scleral reinforcement procedure resulted in minimal endothelial cell loss, according to a study presented at the…

KIAWAH ISLAND, S.C. — In patients with proliferative diabetic retinopathy, ranibizumab delivered with the Port Delivery System…

PHOENIX — A single injection of sura-vec reduced the severity of nonproliferative diabetic retinopathy for up to 2 years,…

DENVER — In a phase 1b trial, subretinal delivery of a human stem cell-derived retinal pigment epithelium yielded visual…

Longer-term dual antiplatelet therapy with clopidogrel and aspirin prevented ischemic events without raising bleeding risk in a…